These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3575350)

  • 21. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
    Titeler M; Seeman P
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M; Hall JM; Frankham PA; Strange PG
    J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dopaminergic binding site in the high speed supernatant of steer anterior pituitary homogenates.
    Kerdelhue B; Weisman AS; Weiner RI
    Endocrinology; 1981 Jul; 109(1):307-9. PubMed ID: 7238409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
    Gundlach AL; McDonald D; Beart PM
    J Neurochem; 1982 Sep; 39(3):890-4. PubMed ID: 7097294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical studies of the mesolimbic dopaminergic pathway: [3H]spiperone labels two bindings sites in homogenates of the nucleus accumbens of rat brain.
    Beart PM; McDonald D
    J Neurochem; 1982 Nov; 39(5):1452-60. PubMed ID: 6126526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
    Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial purification of the D2 dopamine receptor from bovine caudate nucleus.
    Williamson RA; Worrall S; Chazot PL; Strange PG
    Biochem Soc Trans; 1988 Aug; 16(4):450-2. PubMed ID: 2974812
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute changes in the state of dopamine receptors; in vitro monitoring with 3H-dopamine.
    Bacopoulos NG
    Life Sci; 1981 Dec; 29(23):2407-14. PubMed ID: 6172691
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.